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Abstract
In order to further characterize its role in pathogenesis and to establish whether its overproduction can lead to
eukaryotic tumor cell death, Salmonella strains able to express its virulence factor SpvB (an ADP-ribosyl transferase
enzyme) in a salicylate-inducible way have been constructed and analyzed in different eukaryotic tumor cell lines. To
do so, the bacterial strains bearing the expression system have been constructed in a ∆purD background, which
allows control of bacterial proliferation inside the eukaryotic cell. In the absence of bacterial proliferation, salicylate-
induced SpvB production resulted in activation of caspases 3 and 7 and apoptotic cell death. The results clearly
indicated that controlled SpvB production leads to F-actin depolimerization and either G1/S or G2/M phase arrest in
all cell lines tested, thus shedding light on the function of SpvB in Salmonella pathogenesis. In the first place, the
combined control of protein production by salicylate regulated vectors and bacterial growth by adenine concentration
offers the possibility to study the role of Salmonella effectors during eukaryotic cells infection. In the second place,
the salicylate-controlled expression of SpvB by the bacterium provides a way to evaluate the potential of other
homologous or heterologous proteins as antitumor agents, and, eventually to construct novel potential tools for
cancer therapy, given that Salmonella preferentially proliferates in tumors.
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Introduction
Salmonella enterica serovar Typhimurium (S. Typhimurium)
is probably the pathogen that has been most extensively
studied and exploited as an anti-tumor agent. It can invade
different host cells, such as epithelial cells, macrophages and
dendritic cells. Most importantly, Salmonella is capable of
preferentially colonizing and proliferating in solid tumors to
levels nearly 1000-fold higher than normal tissue, a situation
that usually results in tumor growth inhibition [1]. Additionally,
Salmonella is not only able to colonize large solid tumors, but
also to accumulate in metastases when systemically
administered [2,3]. The genetic manipulation of Salmonella is
well developed and a variety of attenuated strains with
mutations that render the bacteria safe for the host have been
characterized [4,5]. The administration of attenuated
Salmonella strains expressing different anti-tumor agents has
been used in recent years with promising results in tumor
regression [6–9].
After ingestion into the digestive tract, Salmonella induces
macropinocitosis by epithelial cells through the injection of
bacterial effector molecules that manipulate the host
cytoskeleton [10]. This injection is mediated by the Type Three
Secretion System (TTSS) encoded in the Salmonella
pathogenicity island-1 locus (SPI-1). Inside the eukaryotic cell,
bacteria remain enclosed in a membrane-bound vacuole
termed Salmonella-containing vacuole (SCV). Effectors
translocated by this TTSS and by a second TTSS (TTSS-2),
encoded by the SPI-2 locus, contribute to the intracellular
survival and replication of the bacteria (reviewed in 11). Once
established inside epithelial cells, Salmonella is able to
replicate and induce apoptosis after 18-24h [12,13].
Many Salmonella serovars, such as S. Typhimurium, carry
an additional locus called spv [14] encoded by the Salmonella
virulence plasmid (or chromosomally in some strains) that
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enhances virulence in animals and humans [14–18]. This locus
encodes, among others, the SpvB protein, whose C-terminal
domain confers ADP-ribosyl transferase activity [19,20]. This
activity covalently modifies G-actin monomers thus preventing
their polymerization into F-actin filaments, which causes the
loss of the eukaryotic actin cytoskeleton [18,21–23]. These
results have been shown using different approaches, such as
adding purified SpvB protein to cell lysates, transfecting
epithelial cells and macrophages to transiently express the
protein, or infecting macrophages and epithelial cells with
different Salmonella SpvB mutants to analyze their efficiency in
depolymerizing actin. It is thought that SpvB is delivered into
the eukaryotic cytosol via the SPI-2 TTSS [18,23–25] and that
both the SPI-2 TTSS and SpvB are required for the late
apoptosis produced by Salmonella in macrophages and
epithelial cells [13,16]. However, the mechanism connecting
SpvB to apoptosis induction remains unknown.
In recent years, the use of compounds that inhibit or prevent
actin polymerization to reduce the growth of several tumor cell
lines has been investigated [26,27]. Cytotoxic agents that
interfere with cytoskeleton dynamics have a recognized
potential utility in the cancer treatment. For instance, natural
toxins such as pectenotoxin 2, isolated from dinoflagellates,
have been shown to have a potent apoptosis inducing effect on
human cancer cells lines [28], together with G2/M arrest and
endoreduplication [28–31]. Since purified SpvB is unable to
enter eukaryotic cells [22], here we have used Salmonella to
express SpvB in different cell lines to explore the possibility of
its use in anti-tumor therapy. The ability to flexibly control
expression levels and timing should help us better understand
the role of SpvB in pathogenesis and apoptosis induction. To
this end, we have used a set of vectors and GFP-tagged
Salmonella strains, recently developed in our laboratory, that
drive the expression of heterologous proteins inside the
eukaryotic cytoplasm when salicylate or acetyl salicylate is
added to the cell culture [32–35]. The system combines a set of
salicylate-regulated elements from Pseudomonas putida that
work in a cascade, with a regulatory module integrated in the
chromosome and an expression module in a plasmid. We
demonstrate that upon salicylate induction, SpvB production
depolymerizes F-actin in different tumor cell lines. Using a purD
mutation, that prevents proliferation of the bacteria and protein
expression inside the eukaryotic cell, we show that SpvB leads
to a G1/S or G2/M arrest of the cell cycle and induces
apoptosis via caspase-7 and -3.
Materials and Methods
Strain, plasmids and growth conditions
All plasmids and bacterial strains used in this work are
described in Table S1. Cultures were grown aerobically at 180
r.p.m. and 37°C in Luria-Bertani (LB) medium and
supplemented when necessary with ampicillin (100 μg/ml).
Transductional crosses using phage P22 HT 105/1 int201 [36]
were used for transferring chromosomal markers among the
strains. The transduction protocol has been described
elsewhere [37].
Cell cultures
HeLa (human cervix carcinoma cells), MCF-7 and MDA-
MB-231 (human breast cancer cells), PANC-1 (human
pancreatic adenocarcinoma cells) [38], HCT116 (human
colorectal cancer cell) and RH-30 (human rhabdomyosarcoma
cells) lines were a kind gift from J. Casadesús, A. López-Rivas
D. Tuveson and J. Carvajal, respectively and previously
obtained from the American Type Culture Collection (ATCC,
Manassas, VA, USA). HeLa Kyoto cells expressing H2B-
mCherry and mEGFP-α- tubulin [39] were provided by Dr D.
Gerlich. Cells were cultured at 37°C in a 5% CO2 humidified
incubator, and maintained in a Dulbecco's modified Eagle's
medium (DMEM) (Sigma-Aldrich, Germany) supplemented with
2 mM L-glutamine and 10% heat-inactivated fetal bovine serum
(FBS) containing a Penicillin-Streptomycin mixture (PAA
laboratories GmbH, Austria).
Molecular biology general procedures
All DNA manipulations were performed following standard
protocols [40]. The spvB gene was amplified by PCR using
total genomic DNA from Salmonella 14028 strain and primers
spvBF1 (5'-cgtatcatatgttgatactaaatgg-3') and spvBR1 (5'-
atatgatatcctatgagttgagtac-3') that contain the NdeI and EcoRV
restriction sites, respectively. The 1.78-kb NdeI- EcoRV
fragment was cloned in pMPO52 [34] into the same restriction
sites. The resulting plasmid pMPO1036 contained spvB gene
preceded by T7 SD sequence under the control of Pm
promoter.
Additionally, we cloned the 1.844 kb SmaI and SalI fragment
from pMPO1036 into the same restriction sites of pMPO60
[34], generating the low-copy number version pMO1044. This
plasmid possesses the nasF attenuator to reduce its basal
expression level.
To generate SpvB C-terminally fused to the HA epitope,
spvB gene was amplified by PCR using total genomic DNA
from Salmonella 14028 strain with primers spvBF1 and
spvBSalIR (5'- gatgtcgacgctgagttgagtaccctc-3') that contain the
NdeI and SalI restriction sites, respectively. The 1.775-kb NdeI-
SalI fragment was cloned in pMPO1004 into the same
restriction sites, generating the plasmid pMPO1612.
Construction of deletion mutants in Salmonella strains
For the construction of spvB and purD mutant strains, the
"One Step Deletion" approach was used to replace target
genes by the kanamycin resistance cassette [41]. The primers
used for the amplification of kanamycin resistance gene from
pKD4 were antispvBfin-P1 (5'-
gggatccacaatttacaatgctttcgattttgagtttagtatttggagggtgtaggctggag
ctgcttc-3') and SpvBprinP2 (5'-
ctttcctgccaaaagggggcaaggcgctgagtcagtcaggccctgacggccatatga
atatcctccttag-3'), or antifinpurD-P1 (5'-
ccagcgcggtggcgcacagtacgcggccgccgctggtcaacacgcggtcgtgtag
gctggagctgcttc-3') and purDprin-P2 (5'-
ccgcgttgcagaacgtggctatcggcgtcaccgatattccggcgctgctgcatatgaat
atcctccttag-3') for spvB and purD gene deletion, respectively.
After the generation of primary mutants, the ΔspvB mutation
was transduced by P22 phage into a fresh 14028 strain bearing
the regulatory module of the salicylate inducible cascade
Ectopic SpvB Expression Induces Cell Cycle Arrest
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expression system in its chromosome (MPO95). The kan gene
was subsequently deleted using pCP20 and then, ΔpurD::kan
mutation was transduced by P22 phage into the ΔspvB deletion
strain (MPO302) to generate the double mutant strain
MPO325.
In vitro bacterial infection of tumor cells
Infection experiments were performed essentially as
described elsewhere [34,42] with minimal modifications. Cells
were cultured in 24-well plates at a density of 105 cells per well
20 hours before infection. An overnight Salmonella culture was
diluted 1:33 on fresh LB supplemented when necessary with
ampicillin (100 μg/ml) and incubated at 37°C during 3.5 hours.
Cells were equilibrated for 30 min in Earle’s buffered salt
solution (EBSS) (Sigma-Aldrich, Germany) before infection.
Bacteria were added at multiplicity of infection (m.o.i.) of
100:1-250:1 allowing the infection to proceed for 15 min at
37°C and 5% CO2. Wells were washed twice with Phosphate
Buffer Saline (PBS) and incubated for 1 hour with DMEM
containing 100 μg/ml gentamicin (PAA laboratories GmbH,
Austria) to kill extracellular bacteria. When using ΔpurD
mutants, the medium also contained 366 μM adenine
hemisulfate salt (normal adenine concentration). After that, the
antibiotic concentration was reduced to 16 μg/ml, and 2 mM
sodium salicylate (Sigma-Aldrich, Germany) was added to the
culture medium to induce the SpvB expression. Adenine
concentration was reduced 40-fold 1 hour after induction, to
avoid bacterial proliferation (low adenine concentration). This
adenine concentration was selected because was the highest
concentration tested that did not allow the bacterial
proliferation. Cells were incubated in this medium (DMEM
containing salicylate and, when necessary, low adenine) until
analysis.
In order to reach higher infection rates, a m.o.i. of 250:1 was
used in cell death assays and Western blot analysis.
Invasion and intracellular replication assays
Different tumor cell lines (105 cells/well) were infected with
MPO302 or MPO325 Salmonella strains at m.o.i. 100:1, as
described before. 3 hours after salicylate induction, cells were
washed with PBS and treated with trypsin. After centrifugation,
the cell pellet was resuspended in 400 μl of PBS and analyzed
by a FACSCalibur flow cytometer (Becton Dickinson, Franklin
Lakes, NJ. USA). 10,000 events were analyzed using
CellQuest software (Becton Dickinson) for each sample.
Fluorescence microscopy
For fluorescence staining of F-actin, infected cells were
grown on glass coverslips (12 mm, Thermo Scientific) and cell
samples were taken 2-20 hours after induction and rinsed twice
with PBS. Cells were subsequently fixed in 3.7%
paraformaldehyde for 10 min at room temperature, and
permeabilized in 0.1% Triton X-100 for 10 min. Thereafter, cells
were briefly washed twice with PBS and incubated for 15 min
with PBS containing Hoechst 33258 (1μg/ml) and 1:100
phalloidin-rhodamine (R415; Invitrogen Molecular Probes,
USA) at room temperature in the dark. After washing with PBS
(three times), the coverslips were mounted on slides and
visualized with a confocal microscope Leica SPE (630X) or a
fluorescence microscope Leica DMI4000B (320X) (Leica
Microsystems GmbH, Wetzlar, Germany).
Cell death assays
Cells were seeded onto a 24-well plate (Nunc, Denmark) at a
density of 5x104 cells per well and were infected with
Salmonella strains (14028, MPO302, MPO305 and MPO325)
at a multiplicity of infection of 100:1 as described before. 24
hours after salicylate induction, culture supernatants were
collected for analysis (experimental release sample). Cell death
was determined by measuring lactate dehydrogenase (LDH)
release in confluent infected cultures using CytoTox 96 non-
radioactive cytotoxicity assay kit (Promega, USA), according to
the manufacturer. The percentage of cytotoxicity was
calculated as 100 x [(experimental LDH release − spontaneous
LDH release)/ (total LDH release − spontaneous LDH release)],
in which spontaneous LDH release was the level detected in
the supernatant of an uninfected non-confluent HeLa cell
culture. Total release is the activity in infected HeLa cell
lysates. 1 μM staurosporine (STS) (Sigma-Aldrich, USA) was
used as a control of cell death.
Cell cycle analysis
Cell distribution was determined by flow cytometry of
propidium iodide (PI)-stained nuclei at the indicated times
points after induction. The harvested cells (~5x105 cells) were
washed twice with PBS and fixed in 80% cold ethanol at -20°C
for at least 24 hours. After fixation, cells were washed twice
with PBS containing 0.1% BSA and the pellets were
resuspended in phosphate-citrate buffer (0.2 M Na2HPO4,
0.1M citric acid pH 7.8) for 5 minutes at RT. After centrifugation
at 500 g for 5 min, the cell pellet was resuspended in DNA
staining solution (100 μg/ml of RNase A (R5125; Sigma-
Aldrich), 40 μg/ml of PI, 0.1 mM EDTA pH 8 and 0.1% Triton
X-100, in PBS) and incubated 30 min at 37°C in the dark.
Samples were analyzed by flow cytometry. 10,000 events for
each sample were analyzed using CellQuest software to
determine the relative DNA content based on the presence of a
red fluorescence and to evaluate the percentages of cells in
sub-G1 (apoptotic cells), G0/G1, S, and G2/M phases. Results
were presented as mean ± SD. Statistical analysis was
performed using Student's t test. p < 0.05 was regarded as
statistically significant.
Live-infected cells imaging
HeLa Kyoto cells stably expressing H2B-mCherry and
mEGFP-α-tubulin were plated on 35-mm glass bottom culture
dishes (P35GC-1.5-10-C; MatTeK) and infected at m.o.i 100:1
with Salmonella MPO325 bearing pMPO61 or pMPO1044, as
described before. After 1 hour of incubation in DMEM
containing 16 μg/ml gentamicin, normal adenine concentration
and sodium salicylate, the culture medium was replaced by 3
ml of Leibovitz’s L-15 medium (Sigma-Aldrich) supplemented
with 2 mM L-glutamine and 10% FBS, and containing 16 μg/ml
gentamicin, a low adenine concentration, and 2 mM sodium
salicylate. Live-cell imaging was performed under Deltavision
widefield microscope systems (Applied Precision, Issaquah,
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WA) equipped with a thermostat (37°C). Images were acquired
using a 60x objective every 30 minutes for 20 hours as an
image stack of 16- X 1-μm z-planes with 2 X 2 binning and
analyzed using ImageJ software.
Analysis of the ability of Salmonella deletion mutants
to produce and translocate proteins into live eukaryotic
cells
HeLa cells were infected with purD+ (14028 and MPO302) or
purD- (MPO305 and MPO325) strains bearing pMPO1004 as
described previously. 24 hours post-infection, cells were
detached by trypsin treatment, washed twice with PBS and
then resuspended on 100 μl lysis buffer [43] and kept on ice for
30 minutes. The cell lysate was centrifuged at 20,000 g for 10
minutes and the supernatant was transferred to new tubes.
Protein concentrations in the supernatant were determined by
the RC DC Protein Assay protocol (BioRad, USA) and 30 μg of
protein from the supernatant were loaded for 12.5% SDS-
PAGE. After electrophoresis and Western blotting,
immunoreactive products to anti-HA (1:5000 dilution) were
detected by the SuperSignal West Dura Extended Duration
Substrate reagents, according to the manufacturer's protocol
(Pierce Protein Research Products, Thermo Scientific, USA).
HA antibody was purchased from Covance (USA) and α-
tubulin antibody from Calbiochem (USA).
Caspase and PARP Western blot analysis
HeLa and MCF-7 cells previously infected with MPO325
bearing pMPO52 or pMPO1036 were induced as described
before. 24 hours (HeLa) or 48 hours (MCF-7) after induction,
cells were collected by trypsin treatment, combined with cell
culture media containing floating cells, and centrifuged. The
cell pellet was washed with PBS and lysed in Urea lysis buffer
(7M Urea, 2M Thiourea, 4% CHAPS, 40 mM DTT, protease
inhibitors) on ice for 30 minutes. The cell lysate was
centrifuged at 20,000 g for 10 minutes. Supernatant protein
concentration was determined by the RC DC Protein Assay kit
(BioRad, USA). Equal amounts of protein (50-100 μg/lane)
were subjected to SDS-polyacrylamide gel electrophoresis
under standard conditions. After electrophoresis and Western
blotting, immunoreactive products to anti-caspase-3 (1:500
dilution), anti-caspase-7 (1:1000), anti-PARP (1:1000), anti-
DnaK (1:5000) and anti-α-tubulin (1:10,000) were detected as
above. Anti-α-tubulin antibody was used to ensure equal
protein loading per lane. Antibodies against PARP (#9542),
caspase-3 (#9662, #9664) and caspase-7 (#9492) were
obtained from Cell Signaling Technology (USA). Anti-Dnak
(mAb, 8E2/2) was obtained from Enzo Life Sciences (USA).
Anti-mouse (A9044)- and anti-rabbit (A8275)- secondary
antibodies were obtained from Sigma-Aldrich (Germany).
Results
Controlled expression of SpvB by Salmonella in
eukaryotic cells depolymerizes F-actin and induces cell
cycle arrest
We have utilized different salicylate inducible expression
vectors to produce the SpvB protein by Salmonella in the
cytosol of HeLa and MCF-7 cells and to analyze the effects of
its controlled production. The producing Salmonella strain
MPO302 is a spvB deletion mutant which bears in its
chromosome the regulatory module of the salicylate inducible
cascade expression system and a Ptac-gfp cassette, to track
the bacteria [34]. Briefly, in the regulatory module, constitutively
expressed NahR is activated by salicylate binding and
promotes xylS2 transcription from Psal. In turn, XylS2
enhances the transcription of heterologous genes from the Pm
promoter in the expression module. In addition, this system
includes a terminator/antiterminator (nasF/nasR) circuit, from
Klebsiella oxytoca, designed to reduce basal expression levels
to detection limits [32,44].
We first constructed the plasmid pMPO1036, which contains
the Salmonella spvB coding sequence cloned downstream of
the Pm promoter and the strong T7 ribosome binding site
(RBS) sequence, that achieves high translation levels [34]. The
Salmonella strain MPO302, carrying either the plasmid or the
empty vector pMPO52, was used to infect HeLa and MCF-7
cells. Once the invasion was established, SpvB expression was
induced with salicylate and cell cultures were analyzed by
fluorescence microscopy 4 hours after induction. As shown in
Figure 1A and Table 1, most HeLa and MCF-7 cells infected
with SpvB-expressing Salmonella have lost their actin filaments
4 hours after salicylate induction (85% and 73% respectively),
as determined by phalloidin-rhodamine staining and
fluorescence microscopy. When cultures were analyzed 20
hours after induction, these cells showed a drastic decrease in
proliferation (data not shown) and the frequency of infected
cells without actin filaments increased to 99% in the case of
HeLa, while MCF-7 showed little change (Table 1). Consistent
with the observed depolymerization of F-actin cytoskeleton,
Hoechst staining revealed a failure in cytokinesis, as 50% of
infected cells contained two nuclei in both cell lines 20 hours
after induction (arrows in Figure 1B and Table 1). Hoechst
staining also detected the presence of cells with fragmented
nuclei, suggesting that filament depolymerization and
cytokinesis failure could lead to apoptosis induction.
Next, we tested the ability of SpvB to depolymerize actin
when expressed from derivatives of pWSK29 [45], a stable low
copy vector used in animal experiments. To that end, we
cloned spvB in salicylate-regulated pWSK29 derivative vectors
bearing the T7 RBS, as well as the nasF attenuator between
the promoter and the spvB gene to reduce basal transcription
[34]. We observed a similar effect on actin depolymerization
and accumulation of binucleated cells 4 and 20 hours after
salicylate induction, which indicated that sufficient SpvB
production can be achieved even with a low copy number
vector. Figure S1 shows the results 4 hours after salicylate
induction using low copy number plasmids.
Ectopic SpvB Expression Induces Cell Cycle Arrest
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Figure 1.  Effect of salicylate-dependent SpvB intracellular overexpression in tumor.  cells.
(A) Fluorescence microscopy analysis of HeLa or MCF-7 cells infected with Salmonella MPO302 (ΔspvB) bearing the high-copy
plasmids pMPO52 (empty vector) or pMPO1036 (SpvB) 4 h post-induction (320x). Scale bar: 50 μm. The MPO302 strain
constitutively expresses GFP (green). The cells were simultaneously stained with phalloidin-rhodamine for polymerized actin (red)
and Hoechst 33258 to stain eukaryotic and bacterial DNA (blue). (B) Higher magnification of infected HeLa cells culture 20 h post-
induction using the Confocal Microscope Leica SPE (630x). Many infected cells show two nuclei (arrows) and some present
fragmented nuclei (yellow box inset). Scale bar: 20 μm.
doi: 10.1371/journal.pone.0078458.g001
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Salmonella purD mutant do not induce cell death per se
but can be induced to produce protein inside the
eukaryotic cell
To further explore the consequences of the controlled
expression of SpvB in eukaryotic cell cultures by Salmonella,
we analyzed its effect on cell death. Apoptosis is a relatively
late epithelial cell response to Salmonella infection [12,13] and
to characterize it, the infected cells must be maintained in
cultures for at least 48 hours. Since Salmonella proliferation
itself and the production of certain proteins during the first 7-8
hours of infection cause host cell death [12,13,46,47], in order
to evaluate the SpvB overexpression effects, intracellular
bacterial growth and effector proteins production must be
restricted. It has been shown that a purD mutant is invasion
proficient but unable to proliferate intracellularly once inside the
eukaryotic cell and this proliferation deficiency can be
temporally suppressed by adding adenine to the culture
medium [48]. Therefore, we generated a purD mutation in the
previously described Salmonella strain MPO302, to get the
strain MPO325. In this way, intracellular proliferation and SpvB
production would be controlled by the amount of adenine and
the presence of salicylate in the culture medium respectively.
In order to assess the suitability of this mutant, we first
compared its infection capacity with that of its isogenic purD+
strain infecting HeLa and MCF-7 cells. Quantification by flow
cytometry analyses shown in Table 2 indicates that both strains
have similar infection efficiencies.
Secondly, we determined the intrinsic capacity of the purD
mutant to induce cell death when infecting cell cultures in the




cells   





HeLa 4 h 61.33 ± 6.20 85.41 ± 7.11 9.17 ± 3.39
HeLa 20 h 55.38 ± 16.60 98.99 ± 2.11 48.01 ± 13.16
MCF-7 4 h 90.86 ± 3.23 72.75 ± 9.98 3.33 ± 1.14
MCF-7 20 h 78.46 ± 7.39 75.96 ± 9.69 57.94 ± 9.34
Data were obtained by counting ~ 100 cells per field 4 and 20 h post-induction.
Values are means ± standard deviations of five independent fields.
doi: 10.1371/journal.pone.0078458.t001
Table 2. Invasion and intracellular replication efficiency of
Salmonella strains in tumor cells.
Cell line MPO302 ΔspvB MPO325 ΔspvBΔpurD
HeLa 65,06 ± 3,32 61,73 ± 1,35
MCF-7 77,90 ± 1,64 72,72 ± 2,32
Infected cells with a multiplicity of infection of 100:1 were harvested 4 h post-
infection and 10,000 events were analysed by flow cytometry. Values represent
percentages of infected cells (green fluorescent cells) and are the means ±
standard deviations of three independent experiments.
doi: 10.1371/journal.pone.0078458.t002
presence of normal or low concentrations of adenine, by
measuring cytosolic lactate dehydrogenase (LDH) release
(Figure 2). We performed LDH assays with the purD+ and purD-
strains in different genetic backgrounds and two adenine
concentrations, as described in materials and methods. purD+
and purD- strains were used in HeLa infection experiments in
which the culture medium was supplemented with the normal
concentration of adenine either for 24 hours or for 2 hours,
followed by 22 hours with a low adenine concentration. This
adenine concentration was selected because it was the highest
concentration tested that did not allow for bacterial proliferation
in a purD- background (data not shown). As a control, the LDH
release of a culture infected with a purD- strain with a normal
adenine concentration was also tested. The results clearly
demonstrated that although the wild type and spvB mutant
strains are able to induce cell death when cultured with low
concentration of adenine, the purD mutant is unable to produce
cell death under the same conditions. However, when adenine
was present in the medium at higher concentration, the cell
death induction of the purD- was similar to that of the isogenic
purD+ strain. This behavior of the purD mutant was
independent of the presence or absence of the ΔspvB
mutation. These results confirm that the adenine requirement
of the purD mutant prevents its induction of cell death. LDH
release experiments using MCF-7 cells showed similar results
(data not shown).
Figure 2.  Cytotoxicity of purD mutant on HeLa.  cells 24 h
post-infection.
The cell death induction capacity of Salmonella strains was
measured by the LDH release method. Staurosporine (STS)
was used as a positive control for cell death. All samples were
compared with the level of spontaneous cell death in non-
infected cells. The results are the mean ± SD of three
independent experiments. Culture medium was supplemented
for two hours with normal adenine concentration and then was
replaced by a low adenine concentration medium, except the
sample on the right, which was supplemented with normal
adenine concentration (+Ade). The multiplicity of infection was
100:1.
doi: 10.1371/journal.pone.0078458.g002
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Finally, we examined the capacity of this mutant to produce
and translocate proteins into the eukaryotic cytosol in response
to salicylate under the conditions that restrict bacterial growth.
To that end, we used an expression vector that carries the
signal peptide of the virulence factor SspH2 fused to the HA
epitope downstream of the Pm promoter. This vector allows the
expression and translocation of the SspH2-HA fusion protein
by Salmonella TTSS-2 in the presence of salicylate [34]. purD+
and purD- strains bearing this plasmid were used in HeLa
infection experiments in which the culture medium was
supplemented with the two concentrations of adenine
described above. As expected, the purD mutants required the
normal concentration of adenine in the medium to obtain a
production and secretion of protein equivalent to strains purD+
and were unable to produce or secrete when adenine was
absent (Figure 3). However, the condition that limited the
adenine concentration 2 hours after infection still allowed
detection of the salicylate-induced production and secretion of
proteins. Finally, this experiment also showed that the
presence of ΔspvB allele does not affect the SspH2-HA
production or translocation.
Taken together, these results indicate that the purD mutation
and the use of appropriate adenine concentrations allow the
induction of gene expression in response to salicylate while
restricting bacterial proliferation and intrinsic induction of cell
death caused by bacterial infection. Therefore, the conditional
expression system in the purD- background used here
represents a useful tool to study the effect of SpvB or other
virulence factors in Salmonella infected cells independently of
those produced by the normal bacterial proliferation during the
infection cycle.
Effect of the regulated intracellular SpvB expression in
a purD mutant
Having established the appropriate genetic background and
culture conditions for protein production, we tested the ability of
this strain to reproduce the effects of the SpvB overexpression
under non-proliferating conditions. To this end, we infected
HeLa and MCF-7 cells with purD- Salmonella strains carrying
either the high copy vector overproducing SpvB (pMPO1036)
or the empty vector (pMPO52). The culture medium was
supplemented with normal concentration of adenine for 2 hours
to allow the infection establishment and protein expression.
Subsequently, the adenine concentration was reduced to avoid
bacterial proliferation and the expression of bacterial proteins
involved in cell death induction. The cell cultures were
analyzed by fluorescence microscopy 4 and 20 hours after
salicylate induction. The results (Figure 4) indicate that the
purD- strain was able to reduce cell proliferation, induce actin
depolymerization and the accumulation of binucleated cells
after SpvB overproduction as proficiently as the purD+ strain
(compared to Figure 1) despite the absence of bacterial
proliferation. As shown previously, we observed binucleated
cells and fragmented nuclei.
To prove the induced expression of SpvB within the
eukaryotic cell, we performed a time course for the amount of
this protein in infected HeLa cells. We first constructed the
plasmid pMPO1612, which has the same features as the
pMPO1036 vector but, in this case, SpvB is tagged with two
copies of the HA epitope. We infected HeLa cells with purD-
Salmonella strains as above, carrying either the empty vector
or the plasmid pMPO1612 and determined the presence of the
SpvB-2xHA protein by Western blot analysis using an anti-HA
antibody. As shown in Figure 5, the presence of the tagged
protein can be detected 1 and 4 hours after induction. Finally,
we tested that the expression of this fusion protein also induces
depolymerization of F-actin filaments and double nuclei
accumulation by fluorescence microscopy (data not shown).
Therefore, these conditions make it possible to assess the
specific role of the SpvB effector in cell death and apoptosis
induction independently from bacterial infection.
SpvB regulated production triggers cell cycle arrest in
G1/S, G2/M and cell death
To further characterize the effect on cell cycle progression
and cell viability upon SpvB controlled expression, we infected
HeLa cells using the purD- mutant following the conditions
described above. Cells were harvested 0, 12, 24 and 48 hours
after induction of SpvB expression, and cell cycle progression
was monitored by flow cytometry analysis (Figure 6). SpvB
induced expression inside eukaryotic cells resulted in an
increase of cells arrested with 4N DNA content, which was
accompanied by a decrease in the number of cells with 2N
DNA content. The 4N arrested cells reached almost 50% of the
total population 12 hours after induction. Interestingly, we
detected a necrotic/apoptotic sub-G1 population that increased
(30% at 48 hours) while the arrested population decreased,
showing that actin depolymerization and cell cycle arrest could
lead to cell death. The percentages of cells in G0/G1 or S
phases of the cell cycle decreases 12 hours after induction and
then maintains or increases slightly.
Flow cytometry indicated that the 4N cell population
decreases from 45% to 17% in the last 12 hours, whilst the
subG1 peak increases. This decrease was not observed in the
2N cells (although we cannot discard the possibility that some
Figure 3.  Protein induction and secretion of wt, ∆purD
and/or ∆spvB strains.  HeLa cells were infected with
Salmonella strains in the presence of normal concentration of
adenine. 2 h after salicylate induction, the adenine
concentration was limited in lanes 2, 3, 5 and 6 (Ade) and
normal in lane 4 (+Ade). Sample in lane 1 served as a control
with no adenine added (-Ade). Strains in lane 1: MPO325; 2:
MPO305; 3: MPO325; 4: MPO325; 5: 14028; 6: MPO302.
doi: 10.1371/journal.pone.0078458.g003
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Figure 4.  Cytoskeleton dismantling by intracellular overexpression of SpvB in Salmonella MPO325 (ΔspvBΔpurD).  A)
Merge images of HeLa and MCF-7 cells infected with Salmonella MPO325 bearing the empty vector (pMPO52) or the high-copy
RBST7-SpvB plasmid (pMPO1036) and induced with salicylate for 20 h (320x). Salmonella constitutively express GFP (green).
Eukaryotic nuclei and bacterial DNA were Hoechst stained (blue) and polymerized actin was phalloidin-rhodamine stained (red).
Scale bar: 50 μm. B) Details of HeLa cells infected with MPO325/pMPO1036 20 h post-induction using the Confocal Microscope
Leica SPE (630x). The infected cells lacking actin show double nuclei (white arrow) or fragmented nuclei (yellow arrow). Scale bar:
20 μm.
doi: 10.1371/journal.pone.0078458.g004
Ectopic SpvB Expression Induces Cell Cycle Arrest
PLOS ONE | www.plosone.org 8 October 2013 | Volume 8 | Issue 10 | e78458
of these cells are also dying due to the absence of F-actin),
therefore, the most likely interpretation is that the 4N arrested
cells eventually induce cell death. These 4N cells may
correspond to binucleated cells, observed previously by
microscopy analysis, which had already completed mitosis but
that actin depolymerization made them unable to undergo
cytokinesis (G1/S arrest), and mononucleated cells that after
replicating their DNA, cannot enter mitosis and separate their
chromatids for the same reason (G2/M arrest). To determine
whether only one population of cells or both lead to cell death,
we infected HeLa cells expressing both histone H2B-mCherry
and mEGFP-α-tubulin with the purD mutants as above and
analyzed the cell cycle progression by time-lapse microscopy.
The results show that both mono- and binucleated arrested
cells induce cell death when infected with Salmonella
overexpressing SpvB (Figure 7 and Movies S1, S2 and S3).
Therefore, our results demonstrate that SpvB depolymerizes
actin, consequently preventing both G1/S and G2/M transition
and that blocking either of these transitions inhibits cell
proliferation and induces cell death.
SpvB regulated expression induces activation of
caspases-3 and -7
SpvB is one of the proteins required by Salmonella to induce
caspase-3 dependent apoptosis in eukaryotic cells [13,16]. We
wondered whether regulated expression of SpvB in conditions
in which Salmonella is neither proliferating nor expressing other
proteins could result in apoptotic cell death as suggested by
the nuclei fragmentation and membrane blebbing produced. To
that end, HeLa and MCF-7 cells were infected as previously
described and harvested 24 or 48 hours after salicylate
induction. The induction of apoptosis was analyzed by
Figure 5.  Induced expression of SpvB-HA in tumor
cells.  HeLa cells were infected with Salmonella MPO325
bearing the empty vector (pMPO52) or the plasmid producing
SpvB-2xHA (pMPO1612) and induced by salicylate for
indicated times under the conditions that restrict bacterial
growth as described previously. Whole cell extracts were
subjected to Western blotting to detect HA epitope fused to
SpvB (68 kDa). The bacterial chaperone DnaK (70 kDa) was
used as a control to confirm the presence of bacteria inside the
tumor cell. Equal loading of the samples was confirmed by α-
tubulin (60 kDa).
doi: 10.1371/journal.pone.0078458.g005
detecting the cleavage of PARP, a caspase substrate, by
immunobloting (Figure 8A), following staurosporine treatment
or expression of SpvB. This result was additionally confirmed
by analyzing the activation of the effector caspase-3. As shown
in Figure 8B, cleaved active caspase-3 was detected following
SpvB expression in HeLa cells using an antibody specific for
the cleaved caspase. MCF-7 cells lack caspase-3 [49], as
confirmed by absence of cleaved caspase-3 following
staurosporine treatment (Figure 8B). Therefore, we searched
for the presence of active caspase-7 in the same samples.
Figure 8C shows that SpvB expression increased the active
form of this caspase in HeLa and MCF-7 cells. These results
show that induction of SpvB overexpression can induce
apoptosis in both tumor cell lines even where Salmonella
proliferation is restricted and does not require capase-3, at
least in MCF-7 cells.
HeLa and MCF-7 cells were infected with Salmonella
MPO325 bearing the empty vector or the plasmid producing
Figure 6.  SpvB overproduction leads to cell cycle arrest in
G1/S, G2/M and cell death.  Cell cycle distribution of HeLa
cells infected with MPO325 bearing pMPO52 (empty vector) or
pMPO1036 plasmid (SpvB) at multiplicity of infection 250:1.
The cells were harvested at the indicated times post-induction;
10,000 events were analyzed by flow cytometry for each
sample. DNA content is represented on the x-axis; the number
of cells counted is represented on the y-axis. Graphics are
representative of three independent experiments. Data
represents mean ± SD of three independent experiments. (*p <
0.05, Student's t test).
doi: 10.1371/journal.pone.0078458.g006
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SpvB and induced for 24 or 48 h, respectively. Whole cell
extracts were prepared and assessed by Western blotting for
A) PARP: full-length PARP (116 kDa); cleavage product (89
kDa); B) cleaved caspase-3 (17/19 kDa); C) caspase-7: pro-
caspase-7 (35 kDa); intermediate pro-caspase-7 (32 kDa);
cleaved caspase-7 (11 and 20 kDa). Equal loading of the
samples was confirmed by α-tubulin (60 KDa).
To investigate whether SpvB-induced cell death is
dependent on caspase-3 and -7 activation, we pretreated HeLa
cells with the caspase inhibitor z-VAD-fmk before SpvB
expression induction. Surprisingly, we observed that SpvB-
Figure 7.  Confocal time-lapse imaging of infected cell with Salmonella MPO325 overproducing SpvB.  HeLa cells expressing
H2B-mCherry (red) and mEGFP–α-tubulin (green) were infected with Salmonella MPO325 bearing the empty vector or the plasmid
producing SpvB and induced as in previous figure. Each cell behavior was monitored along the infection. Time is in hours. Maximum
intensity projection of 16 z dimension slices. Scale bar: 15 μm.
doi: 10.1371/journal.pone.0078458.g007
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induced cell death, measured as sub-G1 population, was only
slightly reduced by the caspase inhibitor although the PARP
cleavage was reduced (Figure S2 A and B). Caspase inhibitors
reduce by 27% the sub-G1 population of the cultures infected
with SpvB-expressing Salmonella and 62% when cultures are
treated with latruculin A. These findings resemble other
systems in which caspase inhibitors are unable to prevent cell
death [50–54].
Effect of SpvB expression in different tumor cell lines
To test whether expression of SpvB triggers the same
response in different cell types, we analyzed the response of
other three human tumor cell lines (MDA-MB-231, PANC-1 and
HCT116 and RH30). These cells were infected as before with
the purD mutant MPO325 bearing the vector that expresses
SpvB upon salicylate induction or the empty vector as control.
The consequences of SpvB expression were analyzed by
fluorescence microscopy. As shown in Figure 9, 20 hours after
induction, the F-actin cytoskeleton depolymerization was
observed in all the cells lines tested and many cells undergo an
SpvB-induced G1/S arrest, showing two closely associated
HOECHST-stained nuclei. These results, as well as the
presence of the apoptotic sub-G1 population, were confirmed
by flow cytometry analysis (data not shown). In summary, SpvB
induces F-actin depolymerization, cell cycle arrest and cell
death in different tumor cell lines, suggesting that bacterially-
delivered inducible SpvB expression might represent a
powerful therapy against different types of tumors.
Discussion
In this work we have used Salmonella for the ectopic
expression of its virulence factor SpvB inside eukaryotic
Figure 8.  Apoptosis induction by overproduction of
SpvB.  
doi: 10.1371/journal.pone.0078458.g008
tumoral cell lines by using a salicylate inducible cascade
expression system. These experiments have been carried out
with three objectives: (i) to design a bacterial system of
controlled delivery of virulence or other factors into the
eukaryotic cytosol that allows characterization of their effects
on the eukaryotic cell, (ii) to get insights into the role of SpvB in
the infection process, and (iii) to exploit the apoptosis induction
capacity of SpvB for potential applications in cancer therapy.
Once Salmonella has infected a eukaryotic cell, bacterial
proliferation leads to apoptosis induction and cell death within
18-24 hours due to the expression of certain effector proteins
during the first 7-8 hours of infection. Therefore, to test the role
of specific virulence factors or the effects of a cytotoxic protein
it is necessary to prevent the production of such effectors. An
attenuated purD mutant strain of Salmonella requires adenine
for growth and cannot proliferate or express proteins inside the
eukaryotic cells. However, adding a limited concentration of
adenine can control proliferation of this strain within the cells.
Adenine limitation can reduce or prevent bacterial proliferation
but this can in turn reduce or prevent heterologous protein
production. In fact, heterologous expression was not evident
when adenine was absent from the culture medium (Figure 3).
However, we have found that when infecting in the presence of
a normal concentration of adenine for two hours followed by
incubation of the cells in a medium with a low adenine
concentration, this did not allow sufficient bacterial proliferation
and protein expression to induce cell death but did allow
significant heterologous protein production and secretion in the
first hours (Figure 3). At least in the case of SpvB, production
capacity of the system under these conditions was clearly
higher than the normal SpvB production in the wild type
bacteria (Figure 2), since salicylate-induction of SpvB
expression triggered cell death even without bacterial
proliferation or other proteins expression that were
subsequently diminished by adenine limitation.
The regulatory system that combines the purD mutant and
conditions that circumvent the deleterious effects of Salmonella
proliferation have the potential of regulating the production and
delivery of different factors into the eukaryotic cytosol and to
analyze their effect on the cell physiology or viability.
Therefore, they represent a powerful tool for analyzing the role
of effector proteins in cell culture. This may also be of particular
interest for analyzing the potential role of virulence factors from
other pathogens in Salmonella.
Controlled expression of SpvB by Salmonella infecting either
HeLa or MCF-7 cells led to a rapid loss of the actin
cytoskeleton (Figure 1), an effect visible 4 hours after infection,
followed by cell death. These effects are clearly associated
with SpvB overproduction, since the infection with a wild type
Salmonella strain does not lead to this rapid depolymerization
of the F-actin filaments (data not shown) [16,18]. In addition,
the purD mutant, which cannot proliferate inside the eukaryotic
cells when adenine is limiting, cannot induce cell death when
SpvB is produced from its native gene encoded in the
chromosome (strain MPO305 in Figure 2) but can efficiently
reproduce the phenotypes if SpvB production is induced by
salicylate in the first hours after the infection, even in the
absence of the endogenous copy of spvB (Figures 4, 6 and 7).
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Therefore, we can deduce that SpvB is responsible for cell
death induction under these conditions although we cannot rule
out that other Salmonella proteins produced in the first two
hours are also contributing to the process.
Cell death features observed in this work suggest that, as
previously reported, SpvB expression induces caspase-
dependent apoptosis. These features include nuclei
fragmentation, membrane blebbing, caspase activation and
PARP cleavage induction after controlled SpvB expression.
However, pretreatments with caspase inhibitors showed a
slight decrease in cell death. In part, this could be due to an
inefficient resolution of our system. In a cell culture, all the cells
are sensitive to drug-induced apoptosis and caspase inhibitors
whereas only a fraction of the culture are infected by
Figure 9.  Salicylate dependent overproduction of SpvB in different tumor.  cell lines.
HCT116, MDA-MB-231 and PANC-1 and RH30 cells were infected by Salmonella MPO325 bearing pMPO52 (empty vector) or
pMPO1036 (SpvB) plasmid. The MPO302 strain constitutively expresses GFP (green). The cells were simultaneously stained with
phalloidin-rhodamine for polymerized actin (red) and Hoechst 33258 to stain eukaryotic and bacterial DNA (blue). Scale bar: 50 μm.
(320x).
doi: 10.1371/journal.pone.0078458.g009
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Salmonella and affected by SpvB. With 50-60% of infected
cells, we observed 20-30% of cell death in the whole cell
culture 48 hours after SpvB expression induction. This
percentage may be not high enough to detect a significant cell
death reduction after treatments with caspase inhibitors. On the
other hand, Kurita et al. (2003) have also shown that z-VAD-
fmk inhibitors are unable to prevent DNA fragmentation
induced in eukaryotic cells that express SpvB. The authors
show that intracellular expression of SpvB in transfected Cos-7
cells caused DNA-ladder formation but addition of z-VAD-fmk
inhibitors did not affect apoptosis induction in this system.
Moreover, similar results have been previously obtained with
other systems in which caspase are activated but the inhibitors
are unable to reduce DNA fragmentation [50–54]. In some of
these cases it have been suggested that alternative
mechanisms of cell death, as autophagy, are induced in
addition to apoptosis. Nevertheless, autophagy is an unlikely
consequence of SpvB expression, since actin cytoskeleton is
involved in this process [55,56].
The effect of SpvB on the cytoskeleton dynamics has been
described previously, where transfection of mammalian CHO
cells with vectors expressing spvB resulted in the loss of the
cytoskeleton [22]. Moreover, the mechanism by which SpvB
modifies G-actin monomers to prevent their polymerization in
F-actin filaments has been well characterised in vitro (reviewed
in 20). In addition, it has been reported that Spv proteins
produced in the first few hours after infection are involved in
apoptosis induction [13]. ADP-ribosylation of G-actin is an
efficient strategy adopted by various toxins to disorganize the
cytoskeleton of eukaryotic cells. A number of these drugs such
as pectenotoxin have been shown to induce apoptosis and cell
death since addition to cell cultures resulted in cell cycle arrest
and apoptosis [28,30,31]. However, very little is known about
the connection between this F-actin depolymerisation and cell
death induction.
The actin cytoskeleton, the cell cycle progression and
apoptosis are interconnected processes, although the
mechanisms governing this integration are not well understood.
Many examples have shown that the state of the actin
organization in the cell is critical for the cell cycle progression
[29,57,58]. Therefore, the cell cycle blockage induced by SpvB
might be the ultimate responsible for apoptosis induction and
cell death. On the other hand, the actin structures formed in the
cell are essential for other cellular processes besides cell cycle
progression, such as the regulation of motility, cell shape,
plasma membrane integrity or apoptosis itself [59]. Different
drugs and regulatory proteins affecting actin dynamics have
been used to show that actin can regulate the cell commitment
to apoptosis in animal cells (reviewed in 60). It has been
proposed that alteration of the actin dynamics itself, as the rate
of polymerization/depolymerization, initiates or modulates the
apoptosis signaling (for review see 61). Consequently, it seems
likely that the actin depolymerization, and the subsequent cell
cycle arrest, is also the condition that directly triggers the
apoptosis due to SpvB production.
Similar to other actin modifying toxins, production of SpvB
resulted in cell cycle arrest 12 hours later [29,62]. However, we
have shown that, while these toxins produce a G2/M cell cycle
arrest, SpvB overexpression induces an arrest at both G1/S
and G2/M transition phases, represented by the mono and
binucleated 4N cell in Figures 6 and 7. Moreover, the SpvB-
induced cell arrest may not be completely equivalent to that
previously described since the percentage of endoreduplicated
cells due to SpvB production, (represented by >4N in Figure 6)
is clearly lower than that observed with other actin modifying
toxins [29]. Binucleated cells could be arrested at G1/S
transition phase of the cell cycle because the lack of actin
prevents them from performing cytokinesis. In the same way,
4N mononucleated cells could be arrested after DNA
replication due to the impossibility of activating mitosis in the
absence of actin.
As cited above, it has been reported that SpvB is one of the
proteins necessary for induction of apoptosis and that this is
dependent on caspase-3. However, our results show that SpvB
induction in MCF-7 cells, which lacks caspase-3, also induced
programmed cell death in this cell line, which indicates that
caspase-3 is not essential for this process. We have shown
that the other major protease, caspase-7, is also activated
during SpvB-dependent apoptosis induction in both HeLa and
MCF-7 cells. The most plausible explanation is that caspase-7
takes control over the cell death program in the absence of
caspase-3 and allows development of the process. Thus,
although these caspases are functionally distinct proteases
[63], they seem to be functionally redundant in the SpvB-
induced apoptosis. Alternatively, caspase-7 may be the
caspase actually involved in this process, regardless previous
reports showing a connection to caspase-3.
The Salmonella infection and rapid apoptosis induction due
to Salmonella SpvB overproduction is not restricted to HeLa or
MCF-7 cell lines, but it is a general phenomenon observed in
all tumor cell lines tested. Probably, actin dismantling is such a
strong barrier to cell proliferation that no cell is able to
overcome.
Taken together, our results show that production of SpvB
using the salicylate-inducible system in Salmonella in
eukaryotic cells can be a potentially useful tool in anti-tumor
therapy, regardless the tumor cell type. Thus, putative effector
proteins with unknown function or any other cytotoxic protein
could be analyzed following this procedure to determine its
potential as cancer therapy agent.
Supporting Information
Figure S1.  Effect of intracellular expression of SpvB from
low-copy vectors in tumor cells. Fluorescence microscopy
analysis of HeLa or MCF-7 cells infected with Salmonella
MPO302 (ΔspvB) bearing low-copy plasmids pMPO60 (control)
and pMPO1044 (SpvB) after 4 h post-induction (320x). Scale
bar: 50 μm. MPO302 strain constitutively expresses GFP
(green). The cells were simultaneously stained with phalloidin-
rhodamine for polymerized actin (red) and Hoechst 33258 to
stain eukaryotic and bacterial DNA (blue).
(TIF)
Figure S2.  Effect of the broad-spectrum caspase inhibitor
z-VAD-fmk in cell death. (A) Cell cycle distribution of HeLa
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cells treated with 4 μM latrunculin A (LatA, Sigma) or infected
with Salmonella MPO325 strain producing SpvB for 48 h in the
presence or absence of caspase inhibitor z-VAD-fmk (R&D
Systems) at 40 µM concentration from 1 h prior to infection.
Graphics are representative of three independent experiments.
Data represents mean ± SD of three independent experiments.
(B) Whole-cell lysates were subjected to Western blotting for
full-length PARP (116 kDa) and cleavage product (89 kDa).
Equal loading of the samples was confirmed by α-tubulin (60
kDa). LatA that disrupts cell cytoskeleton was used as a
control.
(TIF)
Movie S1.  Time-lapse imaging of HeLa Kyoto cells
infection with Salmonella bearing the empty vector.
(AVI)
Movie S2.  Time-lapse imaging of HeLa Kyoto cells
infection with Salmonella bearing the SpvB vector. The
movie shows arrested mononucleated cells death.
(AVI)
Movie S3.  Time-lapse imaging of HeLa Kyoto cells
infection with Salmonella bearing the SpvB vector. The
movie shows arrested binucleated cells death.
(AVI)
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